Finasteride
Brand names: Proscar, Propecia
5-Alpha Reductase InhibitorsKey Takeaway
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
How does Finasteride work?
Finasteride works by blocking 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT) — a more potent androgen responsible for prostate growth and scalp hair miniaturization [1][2].
Specifically, finasteride selectively inhibits the type II isoenzyme of 5-alpha reductase, which is predominantly found in the prostate gland, seminal vesicles, liver, and hair follicles [1]. (The type I isoenzyme, found mainly in skin and liver, is not significantly inhibited by finasteride but is targeted by dutasteride, which inhibits both isoforms.)
At the 5 mg dose (Proscar), finasteride reduces serum DHT levels by approximately 70% and intraprostatic DHT by about 80-90% [2]. This reduction causes the androgen-dependent prostatic epithelial cells to undergo apoptosis (programmed cell death), leading to gradual prostatic shrinkage of approximately 20-30% over 6-12 months [3]. This reduces the physical compression of the urethra that causes BPH symptoms.
At the 1 mg dose (Propecia), finasteride reduces scalp DHT sufficiently to halt the miniaturization of hair follicles in androgenetic alopecia (male pattern baldness) [4]. DHT normally causes susceptible hair follicles to progressively shrink, producing thinner, shorter hairs until the follicle becomes dormant. By reducing DHT, finasteride can stop this process and, in many men, partially reverse it.
Importantly, finasteride does not significantly affect testosterone levels — testosterone may actually increase slightly due to the blocked conversion pathway [1].
What to expect when starting Finasteride
Finasteride requires patience — this is not a fast-acting medication.
For BPH (5 mg): Improvement in urinary symptoms typically begins at 3-6 months and continues to improve over 12 months [1]. Unlike tamsulosin which works in days, finasteride gradually shrinks the prostate. Your doctor may prescribe both initially for combined benefit.
For hair loss (1 mg): You may notice reduced hair shedding within 3 months and visible regrowth at 6-12 months [4]. Some men experience temporary increased shedding during the first few weeks as miniaturized hairs are replaced — this is not a reason to stop.
Sexual side effects (decreased libido, erectile dysfunction, reduced ejaculate volume) occur in approximately 3-8% of men [1]. These effects are dose-dependent and typically reverse after discontinuation, though a small number of men report persistent effects (see "post-finasteride syndrome" discussion in FAQs).
PSA monitoring: Finasteride reduces PSA levels by approximately 50%. Your doctor must account for this when interpreting PSA tests for prostate cancer screening [1].
What are the common side effects of Finasteride?
Common
- Decreased libido6.4%
- Erectile dysfunction8.1%
- Decreased ejaculate volume3.7%
- Breast tenderness/enlargement0.5%
- Rash0.5%
- Dizziness0.4%
- Headache0.4%
- Asthenia0.3%
- Testicular pain0.3%
What are the serious side effects of Finasteride?
Serious
- Depression / suicidal ideation
- High-grade prostate cancer
- Male breast cancer
- Severe allergic reaction
- Persistent sexual dysfunction
What drugs interact with Finasteride?
- MinorNo significant pharmacokinetic interactions — Finasteride has a low drug interaction potential. It is metabolized by CYP3A4 but does not significantly inhibit or induce any CYP enzymes. No clinically meaningful interactions have been identified in formal studies.
- MinorAlpha-blockers (tamsulosin) — Combination is intentional and commonly used for BPH (MTOPS trial showed superior outcomes). No pharmacokinetic interaction. The combination provides rapid symptom relief (alpha-blocker) plus long-term prostate shrinkage (finasteride).
- MinorPDE5 inhibitors — No pharmacokinetic interaction. Can be used together safely if needed for concurrent erectile dysfunction.
- MinorSaw palmetto — No formal interaction, but combining finasteride with saw palmetto provides no additional benefit and complicates assessment of efficacy.
Can I eat certain foods or drink alcohol with Finasteride?
Food: Finasteride can be taken with or without food [1]. Food does not affect absorption or efficacy.
Alcohol: No specific interaction between finasteride and alcohol [1]. Moderate alcohol consumption does not affect finasteride's efficacy. However, excessive alcohol can worsen urinary symptoms in BPH patients and contribute to hormonal imbalances.
Soy and Phytoestrogens: Some patients on internet forums discuss soy and phytoestrogen interactions with finasteride. There is no evidence of a clinically meaningful interaction [2].
What is the typical dosage for Finasteride?
BPH (Proscar): 5 mg orally once daily [1]. Can be used alone or in combination with an alpha-blocker (tamsulosin, doxazosin). The MTOPS trial showed the combination reduced clinical progression better than either agent alone over 4.5 years [3].
Male Pattern Hair Loss (Propecia): 1 mg orally once daily [4]. Treatment must be continued indefinitely — hair loss resumes within 12 months of discontinuation. Response should be assessed at 12 months.
No dose adjustment is required for renal impairment. Use with caution in hepatic impairment (decreased metabolism may increase drug levels) [1].
PSA Adjustment: After 6 months of finasteride therapy, multiply the measured PSA value by 2 to estimate the true PSA for cancer screening purposes [1]. Any confirmed increase in PSA during finasteride therapy should be evaluated, even if still in the "normal" range.
Duration: For BPH, finasteride is typically used long-term. For hair loss, it must be continued indefinitely to maintain results.
How much does Finasteride cost?
Generic finasteride is widely available at very low cost. A 30-day supply of finasteride 1 mg (for hair loss) costs approximately $5-15, and 5 mg (for BPH) costs $4-10 at most pharmacies [5].
Cost-saving strategies: - Generic is standard: Both Proscar and Propecia patents have expired. Generic finasteride is FDA "AB" rated - $4 generic lists: Finasteride 5 mg is on most pharmacy discount programs. The 1 mg may or may not be included - Pill splitting (with doctor approval): Some patients prescribed 1 mg for hair loss split the 5 mg tablet (which is cheaper) into quarters using a pill splitter. This is an off-label practice that should only be done with physician guidance - GoodRx coupons: Can reduce costs to $3-8 for a 30-day supply - Avoid brand Propecia: No clinical advantage over generic. Propecia costs $60-90/month vs. $5-15 generic - No insurance coverage for hair loss: Most insurance does not cover finasteride for cosmetic hair loss, but it is covered for BPH diagnosis
Is Finasteride safe during pregnancy or breastfeeding?
Pregnancy (Category X): Finasteride is absolutely contraindicated in pregnancy and in women who may become pregnant [1]. It can cause abnormal genital development (ambiguous genitalia) in male fetuses by blocking the DHT production essential for normal male sexual differentiation.
Handling Warning: Women who are or may become pregnant should not handle crushed or broken finasteride tablets because the drug can be absorbed through the skin [1]. Intact tablets have a coating that prevents skin absorption during normal handling.
Exposure Through Semen: Finasteride is present in semen at concentrations approximately 50-100 times lower than the dose that could affect fetal development. The risk from exposure through semen is considered negligible, and use of condoms is not specifically required, though some clinicians recommend it during the first trimester of a partner's pregnancy [1].
Breastfeeding: Not applicable — finasteride is not approved for use in women.
Male Fertility: Finasteride can reduce sperm count and motility in some men (by 20-30%), though most remain in the normal range. Effects are reversible upon discontinuation [1].
Is there a generic version of Finasteride?
Both Proscar (5 mg) and Propecia (1 mg) patents have expired, and generic finasteride is now the standard dispensed product.
Generic finasteride is available from numerous manufacturers in both 1 mg and 5 mg tablets, all FDA "AB" rated as therapeutically equivalent to the brand products.
The price differential is dramatic: - Propecia (1 mg): $60-90/month - Generic finasteride 1 mg: $5-15/month - Proscar (5 mg): $80-120/month - Generic finasteride 5 mg: $4-10/month
There is no clinical reason to use brand-name finasteride.
For Caregivers
For caregivers:
- Women of childbearing age: Do NOT handle crushed or broken finasteride tablets. The intact coating prevents absorption, but the powder inside can be absorbed through skin and is harmful to male fetuses. - Patience required: Remind the patient that finasteride takes 3-6 months to work for BPH and 6-12 months for hair loss. Encourage persistence. - PSA testing awareness: Ensure the doctor knows the patient takes finasteride when interpreting PSA test results. The value should be doubled. - Sexual side effects: Be supportive if the patient reports sexual side effects. These affect a minority of men and are usually reversible, but can be distressing. - Mood monitoring: Watch for signs of depression, anxiety, or mood changes, and encourage the patient to report these to their doctor. - Medication adherence: Missing doses reduces effectiveness, especially for hair loss where consistent daily dosing is important.
Frequently asked questions about Finasteride
References
- [Regulatory] Proscar (finasteride) [prescribing information]. Merck & Co., Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020180s045lbl.pdf Accessed 2026-02-15.
- [Regulatory] Finasteride - Drug Information. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88cd6e62-9cd3-4523-8c65-df0ffc684148 Accessed 2026-02-15.
- [Clinical] McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of BPH. N Engl J Med. 2003;349(25):2387-2398. https://pubmed.ncbi.nlm.nih.gov/14681504/ Accessed 2026-02-15.
- [Clinical] Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/ Accessed 2026-02-15.
- [Clinical] Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/ Accessed 2026-02-15.
- [Clinical] Traish AM, Hassani J, Guay AT, et al. Adverse side effects of 5alpha-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med. 2011;8(3):872-884. https://pubmed.ncbi.nlm.nih.gov/21176115/ Accessed 2026-02-15.
- [Regulatory] FDA Drug Safety Communication: 5-alpha reductase inhibitors may increase the risk of a more serious form of prostate cancer (2011). https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-5-alpha-reductase-inhibitors-5-aris-may-increase-risk-more-serious-form Accessed 2026-02-15.
- [Regulatory] Propecia (finasteride 1mg) [prescribing information]. Merck & Co., Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf Accessed 2026-02-15.
- [Clinical] McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-1803. https://pubmed.ncbi.nlm.nih.gov/21420124/ Accessed 2026-02-15.
- [Clinical] Belknap SM, Aslam I, Kiguradze T, et al. Adverse event reporting in clinical trials of finasteride for androgenic alopecia. JAMA Dermatol. 2015;151(6):600-606. https://pubmed.ncbi.nlm.nih.gov/25830296/ Accessed 2026-02-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: